Fig. 4

Comparison of HRU during the 12-month observation period between patients developing versus not developing IBD. RA, rheumatoid arthritis; PsA, psoriatic arthritis; PsO, psoriasis; AS, ankylosing spondylitis; IBD, inflammatory bowel disease; HRU, healthcare resource utilization; IRR, incidence rate ratio; CI, confidence interval. * indicates that p-value < 0.05